hydroxyindoleacetic acid has been researched along with Autoimmune Diabetes in 3 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Munawar, N | 1 |
| Bitar, MS | 1 |
| Masocha, W | 1 |
| De Block, CE | 1 |
| Colpin, G | 1 |
| Thielemans, K | 1 |
| Coopmans, W | 1 |
| Bogers, JJ | 1 |
| Pelckmans, PA | 1 |
| Van Marck, EA | 1 |
| Van Hoof, V | 1 |
| Martin, M | 1 |
| De Leeuw, IH | 1 |
| Bouillon, R | 1 |
| Van Gaal, LF | 1 |
| Nolan, B | 1 |
| Mitchell, TH | 1 |
3 other studies available for hydroxyindoleacetic acid and Autoimmune Diabetes
| Article | Year |
|---|---|
Activation of 5-HT1A Receptors Normalizes the Overexpression of Presynaptic 5-HT1A Receptors and Alleviates Diabetic Neuropathic Pain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2023 |
Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.
Topics: Autoantibodies; Biomarkers, Tumor; Chromogranin A; Chromogranins; Diabetes Mellitus, Type 1; Enteroc | 2004 |
Autonomic neuropathy with gastropathy and elevated urinary 5-hydroxy indole acetic acid in insulin-dependent diabetes mellitus.
Topics: Autonomic Nervous System Diseases; Diabetes Mellitus, Type 1; Humans; Hydroxyindoleacetic Acid; Stom | 1996 |